Recent studies have demonstrated that the inhibition of AR protein expression using AR inhibitors enzalutamide, abiraterone, or antisense oligonucleotide (ASO) combined with AKT inhibitors AZD5363 and ipatasertib could effectively impede tumor cells progression [52, 53, 54]. The gene discussed is AKT1; the disease is neoplasm.